Do Breast Cancer Cell Lines Provide a Relevant Model of the Patient Tumor Methylome?

• Leslie M. Cope,

  Affiliation Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Mary Jo Fackler,

  Affiliation Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Zoila Lopez-Bujanda,

  Affiliation Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Antonio C. Wolff,

  Affiliation Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Kala Visvanathan,

  Affiliations Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, Department of Epidemiology, Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• Joe W. Gray,

  Affiliation Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, United States of America

  ⨯
• Saraswati Sukumar,

  Affiliations Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Christopher B. Umbricht

  * E-mail: cumbrich@jhmi.edu

  Affiliations Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯